People who have recovered from COVID-19 carry a potentially powerful weapon against the disease in their veins, and Blood Assurance moved fast to tap that resource in the early days of the pandemic.
“We set up the program in 24 hours, and did a big media launch on a Sunday,” says Dr. Liz Culler, the medical director of Blood Assurance. “We knew we had to put that in place. Within three weeks of the first local case, we were shipping plasma.”
The blood plasma of people who have recovered from COVID-19 contains antibodies to the disease that could help people who are struggling to fight off the virus. The first unit of that plasma to come from the Blood Assurance program went over Easter weekend to a critically ill nurse in Greenville, South Carolina, who recovered quickly once the plasma was administered, Dr. Culler says.
Though there haven’t been conclusive results yet of large studies tracking the effectiveness of these treatments, the anecdotal evidence is very positive and demand for the units is strong, she says.
“We have demand for 50-60 units a day,” she says. “Demand has really increased.”
